At the completion of this activity, the participant will be able to:
1. Explain the etiology of HER2+ breast cancer
2. Recognize the mechanism of action for chemotherapy agents used in HER2+ metastatic breast cancer
3. Identify appropriate monitoring parameters for chemotherapy agents used in HER2+ metastatic breast cancer
4. Describe updates in primary literature for treatment of HER2+ metastatic breast cancer

Session date: 
10/20/2022 - 12:00pm to 1:00pm EDT
Location: 
WPH Conference Center Auditorium and Zoom Webinar
To Join the Webinar: https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454
Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.